News of Note—J&J launches neurovascular business; Olympus to pay $6.6M over superbug outbreak

news of note

> Johnson & Johnson unveiled a new neurovascular business, dubbed Cerenovus, which includes products that the conglomerate's Codman Neuro unit picked up in its acquisitions of Pulsar Vascular and stroke care company Neuravi. Release

> A jury ordered endoscope maker Olympus to fork over $6.6 million in damages to a Seattle hospital. The verdict concludes an eight-week trial surrounding the company's endoscopes and drug-resistant infections. MedCityNews story | Read more

> Roxwood Medical has struck a deal with Abbott to distribute its cardiovascular catheters in the U.S. Release

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Suggested Articles

The FDA approved a new, tiny pacemaker from Medtronic that does not require the wiring of separate electrodes between the implant and the heart.

The respiratory care company Vyaire Medical has brought on a new CEO, Gaurav Agarwal, following a year of new product launches.

Precision oncology firm Notable Labs is launching its first self-sponsored clinical trial, designed from the ground up to help validate its platform.